Adequate organ function
Adequate organ function
Adequate major organ function
Have adequate organ function.
Adequate organ function
Demonstrated adequate organ function within 14 days of Cycle 1 Day 1 (C1D1).
Has adequate organ function
Adequate organ function
Demonstrate adequate organ function as evidenced by laboratory testing
Has adequate organ function.
Adequate organ function at baseline .
Patient must meet the organ function and system function requirements as stated in the protocol
Adequate organ function as measured by various blood parameters
Have adequate organ function.
Demonstrates adequate organ function
Adequate organ function.
Adequate organ function
Adequate organ function
Have adequate organ function
Adequate organ function
Have adequate organ function, including:
Have adequate organ function.
Have adequate organ function.
Adequate organ function
Poor organ function.
Demonstrates adequate organ function.
Adequate organ function.
Good organ function:
Must have adequate organ function.
Demonstrates adequate organ function.
Adequate organ function
Adequate organ function
Has adequate organ function
Have adequate organ function.
Has adequate organ function.
The patient has adequate baseline organ function, as demonstrated by the following:
Organ Function Requirements:
Adequate organ function within 14 days of study registration including:\r\n* Platelets >= 100 x 10^9/L
Adequate organ function within 14 days of study registration including:\r\n* Hemoglobin >= 8 g/dL
Organ function:
Subjects with adequate organ function as measured by:
adequate organ function
Adequate organ system function.
Patients must have adequate major organ function and meet the following criteria:
Demonstrate adequate organ function
Adequate organ function
Adequate baseline organ function within 14 days prior to the first dose of enzalutamide and/or CORT125281
ORGAN FUNCTION AND PERFORMANCE STATUS CRITERIA:
Adequate organ function at screening
Has adequate organ function
Has adequate organ function within 7 days before enrollment
Adequate organ function
-  Has adequate organ function.
Demonstrate adequate organ function
Adequate organ system function.
Have adequate organ function.
Evidence of insufficient organ function as determined by the protocol.
Candidate for pembrolizumab (as determined by physician, and adequate organ function)
Adequate organ function.
HEALTHY SUBJECT: Have adequate organ function
Adequate organ function.
Adequate organ function confirmed at Screening and within 10 days of initiating treatment, as evidenced by:
Adequate organ function within 14 days of study registration
Adequate organ function.
Patient has adequate organ function at Baseline
Adequate organ and neurologic function
Has adequate organ function including:
Adequate organ function
Have adequate organ function.
Adequate organ function
Have adequate organ function.
Potentially eligible for reduced intensity conditioning based on known organ function (formal organ function testing may occur after consent)
Have adequate organ function.
Adequate organ function
Organ function:
Patients must have adequate organ function
Adequate organ function within 14 days of registration
Adequate organ function
Acceptable end-organ function, except for documented exclusions for organ function compromise due to ALL itself
Adequate organ function
Organ Function Requirements:
Adequate organ function as outlined below (unless due to leukemia)
Adequate organ function
Adequate organ function including:
Adequate organ function
All organ function testing should be done within 28 days of study registration
Have adequate organ function.
Adequate organ function.
Adequate organ function
Patient has adequate organ function
Patients must have adequate organ function
Adequate organ system function within 14 days of baseline:
Poor organ function.
Has adequate organ function
Adequate organ function
Adequate organ function
Organ function characterized by ? Grade 1
Have adequate organ function
Patients must have adequate organ and system function.
Organ function must be adequate as follows:
Has adequate organ function
Adequate organ function.
Adequate organ function
Patient must meet the organ function and system function requirements as stated in the protocol
Adequate organ function as evidenced by:
Adequate organ function
-  The participant has adequate organ function:
Demonstrates adequate organ function.
Adequate organ function.
Adequate organ function
Demonstrates adequate organ function.
adequate organ function
Adequate organ function
Adequate organ function
Adequate organ function:
Adequate organ function prior to registration
Adequate organ function
Adequate organ function
Adequate organ function
Demonstrates adequate organ function
Demonstrates adequate organ function.
Adequate organ function
Has adequate organ function
Have adequate organ function.
Adequate organ function as shown by:
Hemodynamically stable and adequate organ function
Poor organ function.
Adequate organ function
Adequate organ function.
Demonstrates adequate organ function.
Adequate organ function
Adequate organ function
Adequate organ function
Chemistry panel obtained 30 days prior to registration on study, with adequate organ function
Have adequate organ function.
Adequate organ function
Adequate organ function
Has adequate organ function.
Patients must have adequate organ function:
Must have adequate organ function as demonstrated by the following:
Adequate Organ Function
have adequate organ function
Adequate organ function
Have adequate organ function.
Demonstrates adequate organ function
Has adequate organ function
Organ Function
Demonstrate adequate organ function as detailed above
Have adequate organ function.
Adequate organ function
Have adequate organ function
Adequate baseline organ function.
Adequate organ function
Adequate organ function
Have adequate organ function including:
Have adequate organ function
Adequate baseline organ function, as demonstrated by the following:
Adequate organ function
Demonstrated adequate organ function within 14 days of treatment initiation.
Have adequate organ function.
Has adequate organ function
Adequate organ function
Adequate organ function including:
Adequate organ function
Adequate organ function.
Adequate organ function
The participant has adequate organ function.
The participant has adequate organ function, including:
Subject has adequate organ function.
Adequate organ function
Adequate organ function
Adequate organ function
Adequate organ function
Adequate organ function
Adequate organ function
Adequate organ function
Adequate organ function
Adequate organ function
Adequate organ function
Adequate organ function including:
Adequate organ function
Adequate organ function within 14 days of dosing
Adequate organ function
Has adequate organ function
Adequate major organ system function
Adequate organ function including:
Adequate organ function including:
Have adequate organ function;
Adequate organ function
Adequate baseline organ function
Have adequate organ system function
Patients with adequate organ function as measured by:
Adequate organ function
Has adequate organ function
The participant has adequate organ function.
Adequate organ function as evidenced by the following laboratory findings:
Adequate organ function within 10 days of Day 1
Has adequate organ function
Demonstrates adequate organ function.
Adequate baseline organ function.
Adequate organ function within 3 weeks prior to first study drug administration as evidenced by:
Adequate organ function per blood work
Adequate organ function
Adequate organ function as shown by:
Adequate baseline organ function
Have adequate organ function
Subject has adequate organ function.
Adequate organ function
Adequate organ function.
Adequate organ function including:
Has adequate organ function, before the first dose of study drug.
Adequate organ function.
Adequate organ function including the following:
Adequate organ system function.
Adequate organ function
Adequate organ function
Demonstrate adequate organ function.
Adequate organ function
Acceptable organ function as evidenced by the following:
Adequate organ function.
Have adequate organ function.
Have adequate organ function.
Have adequate organ function.
Adequate organ function as determined by the following laboratory results, within 28\n             days prior to randomization
Adequate organ function within 14 days of study entry
Adequate organ function
Adequate organ function at baseline:
Have adequate organ function.
Adequate organ function
Adequate organ function, including the following:
Adequate organ function:
Adequate organ function including:
Adequate baseline organ function.
Adequate organ function
Adequate organ function
Organ function </= grade 1.
Adequate organ function
Adequate organ function;
Adequate organ function
Adequate organ system function determined within 14 days prior to first dose of study treatment.
Adequate organ function.
At the time of the CMV specific T cell infusion, the recipient must have adequate organ function as indicated by < grade 3 across all organ systems except for hematologic toxicity
Have adequate organ function, including:
Adequate organ function.
Adequate organ system function.
Patients with adequate organ function as measured by:
Has adequate organ function as determined by laboratory tests
adequate organ function
Adequate organ function, including the following:
Adequate other organ function at screening and enrollment.
Adequate other organ function at screening and enrollment.
Participants must have adequate organ function, including the following:
Life expectancy of at least 12 weeks. - Adequate organ function
All organ function testing should be done within 28 days of study registration
Adequate organ function
Adequate organ function including:
Has adequate organ function.
Has adequate organ function
Adequate organ function including:
Adequate baseline organ function:
Have adequate organ function
Adequate organ function
Organ function requirements:
Adequate organ function determined within 14 days prior to enrollment
Adequate organ function.
Must have adequate organ function, including the following:
Adequate organ function as determined by the investigator
Demonstrates adequate organ function, within 10 days prior to the start of study drug.
Adequate organ function as per protocol.
Has adequate organ function
Adequate organ function
Evidence of adequate organ function by standard laboratory tests.
